Douridas, Gerasimos N. https://orcid.org/0000-0002-8573-7743
Fountoulakis, Andreas
Souglakos, John
Gourtsoyianni, Sofia
Vini, Louiza
Levidou, Georgia
Liakakos, Theodoros
Agalianos, Christos
Dervenis, Christos
Kalogeridi, Maria Angeliki
Karavokyros, Ioannis
Koumarianou, Anna
Kountourakis, Panteleimon
Oikonomopoulos, Georgios
Economopoulou, Panagiota
Sgouros, Joseph
Sgouros, Spiros N.
Stamou, Konstantinos
Triantopoulou, Charikleia
Zacharoulis, Dimitrios
Gouvas, Nikolaos
Xynos, Evangelos
Funding for this research was provided by:
Hellenic Society of Medical Oncology
Article History
Received: 14 September 2019
Accepted: 11 February 2020
First Online: 28 February 2020
Compliance with ethical standards
:
: Dr. Kalogeridi reports non-financial support from Sanofi, outside the submitted work; Dr. Oikonomopoulos reports personal fees from Roche, personal fees from MSD, personal fees from Bristol, outside the submitted work; and ESMO Member; Dr. Xynos reports non-financial support from Johnson & Johnson, outside the submitted work; Dr. Souglakos reports grants from Amgen, grants and personal fees from Roche, grants and personal fees from Sanofi, personal fees from Servier, personal fees from MSD, personal fees from Merck Serono, personal fees from CellGene, outside the submitted work.
: No human participants or animals were involved during execution of this research project.
: For this type of article, informed consent is not required.